Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Theseus Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- 0 vs. Q2 2022
- Shares held
- 34.6M
- −60.7K (−0.2%) vs. Q2 2022
- Total value
- $200.7M
- +$9.08M (+4.7%) vs. Q2 2022
- New holders
- 2
- 17 more added
- Sold out
- 2
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 17,041,668 | $98.8M | 1.96% | 00.0% | Unchanged |
| FMR LLC | 4,803,240 | $27.9M | 0.00% | −380,123−7.3% | Reduced |
| Foresite Capital Management V, LLC | 3,335,346 | $19.3M | 14.87% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,381,489 | $8.01M | 0.00% | −3,794−0.3% | Reduced |
| Foresite Capital Opportunity Management V, LLC | 959,275 | $5.56M | 16.71% | 00.0% | Unchanged |
| Boxer Capital, LLC | 892,057 | $5.17M | 0.29% | 00.0% | Unchanged |
| BlackRock Inc. | 775,590 | $4.50M | 0.00% | +88,231+12.8% | Added |
| Omega Fund Management, LLC | 711,479 | $4.13M | 1.51% | 00.0% | Unchanged |
| Vanguard Group Inc | 625,943 | $3.63M | 0.00% | −3,371−0.5% | Reduced |
| Nextech Invest AG | 611,310 | $3.55M | 1.15% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 504,862 | $2.93M | 2.64% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 437,329 | $2.54M | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 287,395 | $1.67M | 0.00% | +31,256+12.2% | Added |
| State Street Corp | 248,281 | $1.44M | 0.00% | +14,388+6.2% | Added |
| Woodline Partners LP | 236,390 | $1.37M | 0.02% | +24,706+11.7% | Added |
| Farallon Capital Management, L.L.C. | 223,149 | $1.29M | 0.01% | −186,568−45.5% | Reduced |
| Opaleye Management Inc. | 220,650 | $1.28M | 0.53% | +188,350+583.1% | Added |
| Laurion Capital Management LP | 179,619 | $1.04M | 0.03% | 00.0% | Unchanged |
| Wellington Management Group LLP | 172,566 | $1.00M | 0.00% | +112,411+186.9% | Added |
| Ensign Peak Advisors, Inc | 142,598 | $827.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 133,555 | $775.0K | 0.00% | +5,495+4.3% | Added |
| TD Asset Management Inc | 106,948 | $652.0K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 100,000 | $580.0K | 0.02% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 81,899 | $475.0K | 0.13% | 00.0% | Unchanged |
| Walleye Capital LLC | 79,398 | $461.0K | 0.01% | +47,679+150.3% | Added |
| Manufacturers Life Insurance Company, The | 55,883 | $340.7K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 43,327 | $252.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 43,144 | $250.0K | 0.00% | +4,333+11.2% | Added |
| Nuveen Asset Management, LLC | 36,636 | $212.0K | 0.00% | +4,918+15.5% | Added |
| Rhumbline Advisers | 24,848 | $144.0K | 0.00% | +1,443+6.2% | Added |
| BNP Paribas Arbitrage, SA | 15,310 | $88.8K | 0.00% | +15,310 | New |
| Forefront Analytics, LLC | 13,065 | $74.0K | 0.04% | +13,065 | New |
| Deutsche Bank AG | 9,410 | $55.0K | 0.00% | −1,139−10.8% | Reduced |
| New York State Common Retirement Fund | 9,551 | $55.0K | 0.00% | +56+0.6% | Added |
| JPMorgan Chase & Co | 9,159 | $53.0K | 0.00% | +75+0.8% | Added |
| Morgan Stanley | 8,757 | $51.0K | 0.00% | −3,876−30.7% | Reduced |
| American International Group, Inc. | 8,066 | $47.0K | 0.00% | +114+1.4% | Added |
| California State Teachers Retirement System | 6,707 | $39.0K | 0.00% | −559−7.7% | Reduced |
| Bank of America Corp | 5,895 | $35.0K | 0.00% | −499−7.8% | Reduced |
| Barclays PLC | 5,060 | $29.0K | 0.00% | −132−2.5% | Reduced |
| Tower Research Capital LLC (TRC) | 4,420 | $26.0K | 0.00% | +1,757+66.0% | Added |
| STRS Ohio | 2,700 | $15.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,901 | $11.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,433 | $8.00K | 0.00% | −529−27.0% | Reduced |
| Ameritas Investment Partners, Inc. | 889 | $5.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 800 | $5.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 257 | $1.00K | 0.00% | −916−78.1% | Reduced |
| Royal Bank of Canada | 206 | $1.00K | 0.00% | +110+114.6% | Added |
| Credit Suisse AG | 94 | $1.00K | 0.00% | +80+571.4% | Added |
| Wells Fargo & Company | 32 | $0 | 0.00% | −141−81.5% | Reduced |
| Castle Wealth Management LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,402−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,412−100.0% | Sold out |